Press release
May 21, 2026
Press releases
Browse our latest press releases below, or visit our investor site directly for a complete list of all recent and archived press releases.
Press release
May 19, 2026
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Press release
May 7, 2026
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
Press release
April 23, 2026
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
Press release
March 17, 2026
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Press release
March 6, 2026
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Press release
March 2, 2026
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
Press release
February 26, 2026
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Press release
February 24, 2026
Lantheus to Present at March 2026 Investor Conferences
For access to press releases before 2022 and full-text search capabilities, please visit our investor site.